Literature DB >> 28592969

Corrigendum to "Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents".

Amilton Dos Santos-Júnior1, Taciane Barbosa Henriques2, Maricilda Palandi de Mello2, Osmar Henrique Della Torre1, Lúcia Arisaka Paes1, Adriana Perez Ferreira-Neto1, Letícia Esposito Sewaybricker3, Thiago Salum Fontana1, Eloisa Helena Rubello Valler Celeri1, Gil Guerra-Júnior3,4, Paulo Dalgalarrondo1.   

Abstract

[This corrects the article DOI: 10.1155/2016/5872423.].

Entities:  

Year:  2017        PMID： 28592969      PMCID： PMC5448052          DOI： 10.1155/2017/8165368

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN： 1687-8337            Impact factor:   3.257


In the article titled “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents” [1], there was an error in the “Laboratory Evaluation” section, where the selected CYP2D6 SNP is written as rs72552269, and should be corrected to “rs1065852.”
  1 in total

1.  Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents.

Authors:  Amilton Dos Santos-Júnior; Taciane Barbosa Henriques; Maricilda Palandi de Mello; Osmar Henrique Della Torre; Lúcia Arisaka Paes; Adriana Perez Ferreira-Neto; Letícia Esposito Sewaybricker; Thiago Salum Fontana; Eloisa Helena Rubello Valler Celeri; Gil Guerra-Júnior; Paulo Dalgalarrondo
Journal:  Int J Endocrinol       Date:  2016-01-06       Impact factor: 3.257
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.